SFA
RNTX

Sequoia Financial Advisors’s Rein Therapeutics RNTX Stock Holding History

Sequoia Financial Advisors’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Buy
+250,000
New +$303K ﹤0.01% 1783

Other funds holding RNTX

SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Sequoia Financial Advisors's RNTX Position: Q2 2026 in Review

Sequoia Financial Advisors opened a new position in Rein Therapeutics (RNTX) in Q2 2026: 250,000 shares worth $260K. The stake represents ﹤0.01% of the portfolio and ranks #1783 among its holdings.

5 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

  • Sequoia Financial Advisors held 250,000 shares of Rein Therapeutics worth $260K as of Q2 2026.
  • Rein Therapeutics was a new Sequoia Financial Advisors position in Q2 2026.
  • Rein Therapeutics made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1783 holding.
  • 5 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.